<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04788758</url>
  </required_header>
  <id_info>
    <org_study_id>19E.925</org_study_id>
    <nct_id>NCT04788758</nct_id>
  </id_info>
  <brief_title>Geriatric Assessment Screening Tool for the Identification of At-Risk Older Adults Who Are Undergoing Cancer Treatment</brief_title>
  <official_title>Feasibility of Implementation and Assessment of Geriatric Assessment Screening Tool in Outpatient Oncology Clinic</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Thomas Jefferson University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Thomas Jefferson University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This phase II trial investigates how easy it is to incorporate a nursing led geriatric&#xD;
      assessment screening tool into a busy oncology practice, in order to identify at-risk older&#xD;
      adults being evaluated for cancer treatment. This screening tool may help identify at-risk&#xD;
      patients who can be referred for more in depth assessment, allowing for the creation of an&#xD;
      individualized treatment plan that puts the patient's safety and personal goals as a&#xD;
      priority.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      PRIMARY OBJECTIVE:&#xD;
&#xD;
      I. To determine the feasibility of training nurses to administer the Geriatric 8 (G8)&#xD;
      screening tool in an oncology practice, to identify older patients (&gt; 65 years old [y/o])&#xD;
      that would benefit from a more extensive Comprehensive Geriatric Assessment (CGA).&#xD;
&#xD;
      SECONDARY OBJECTIVE:&#xD;
&#xD;
      I. To report the positive predictive value of the G8 screening tool with the final frailty&#xD;
      designation determined by the Comprehensive Geriatric Assessment completed in patients&#xD;
      referred to the Senior Adult Oncology Center (SAOC).&#xD;
&#xD;
      OUTLINE:&#xD;
&#xD;
      PHASE I:&#xD;
&#xD;
      Registered Nurses receive training on how to administer the G8 screening tool utilizing an&#xD;
      Epic flowsheet to patients using a self-directed education module and by direct assessment by&#xD;
      a geriatrician.&#xD;
&#xD;
      PHASE II:&#xD;
&#xD;
      Patients complete the G8 screening tool questionnaire over 10 minutes as part of their&#xD;
      standard initial assessment, and their answers are entered into their electronic health&#xD;
      record (EHR) flowsheet. Patients who score =&lt; 14 on the G8 are referred for a CGA at SAOC,&#xD;
      and these patients and their medical oncologists are made aware. Within 2 weeks of the&#xD;
      initial screening, the results are communicated with the patient and medical oncologist at a&#xD;
      2-hour SAOC visit. Patients with a score of &gt; 15 on the G8 are made aware of their results&#xD;
      without any referral generated.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 29, 2020</start_date>
  <completion_date type="Anticipated">June 2022</completion_date>
  <primary_completion_date type="Anticipated">May 2022</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Health Services Research</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Overall assessment score: Pre</measure>
    <time_frame>Before self-administered learning module</time_frame>
    <description>The score will be a number between 1-20. The responses to two questions of primary interest, assessing their comfort caring for older adults and their comfort in administering the G8 tool, will be binary measurements. The overall assessment scores from pre- and post- self-administered learning module will be compared using paired Wilcoxon test.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Overall assessment score: Post</measure>
    <time_frame>After self-administered learning module</time_frame>
    <description>The score will be a number between 1-20. The responses to two questions of primary interest, assessing their comfort caring for older adults and their comfort in administering the G8 tool, will be binary measurements. The overall assessment scores from pre- and post- self-administered learning module will be compared using paired Wilcoxon test.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of patients screened</measure>
    <time_frame>Up to 30 months</time_frame>
    <description>Will be summarized by sample means, standard deviations and/or percentages.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of patients who refused</measure>
    <time_frame>Up to 30 months</time_frame>
    <description>Will be summarized by sample means, standard deviations and/or percentages.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Time it took to screen</measure>
    <time_frame>Up to 30 months</time_frame>
    <description>Will be summarized by sample means, standard deviations and/or percentages.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of referrals to Senior Adult Oncology Center (SAOC)</measure>
    <time_frame>Up to 30 months</time_frame>
    <description>Will be summarized by sample means, standard deviations and/or percentages.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of completed SAOC visits</measure>
    <time_frame>Up to 30 months</time_frame>
    <description>Will be summarized by sample means, standard deviations and/or percentages.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Positive predictive value of the G8</measure>
    <time_frame>Up to 30 months</time_frame>
    <description>The percentage of patients being determined as vulnerable/frail by Comprehensive Geriatric Assessment (CGA) at SAOC, i.e. the predictive positive value of G8, will be reported with its 95% confidence interval. The summary statistics of additional collected SAOC metrics including the Timed Up and Go test, prior history of falls, cognitive screen, depression screen, mortality prognostication, expected life expectancy, social distress thermometer, Mini Nutritional Assessment (MNA), presence of polypharmacy and inappropriate medications, and Eastern Cooperative Oncology Group (ECOG) score will be reported by means, standard deviations and percentages.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">231</enrollment>
  <condition>Hematopoietic and Lymphoid Cell Neoplasm</condition>
  <condition>Malignant Solid Neoplasm</condition>
  <arm_group>
    <arm_group_label>Health Services Research (G8 screening tool, referral)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>PHASE I: Registered Nurses receive training on how to administer the G8 screening tool utilizing an Epic flowsheet to patients using a self-directed education module and by direct assessment by a geriatrician.&#xD;
PHASE II: Patients complete the G8 screening tool questionnaire over 10 minutes as part of their standard initial assessment, and their answers are entered into their EHR flowsheet. Patients who score =&lt; 14 on the G8 are referred for a CGA at SAOC, and these patients and their medical oncologists are made aware. Within 2 weeks of the initial screening, the results are communicated with the patient and medical oncologist at a 2-hour SAOC visit. Patients with a score of &gt; 15 on the G8 are made aware of their results without any referral generated.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Educational Intervention</intervention_name>
    <description>Receive G8 screening tool administration training</description>
    <arm_group_label>Health Services Research (G8 screening tool, referral)</arm_group_label>
    <other_name>Education for Intervention, Intervention by Education, Intervention through Education, Intervention, Educational</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Screening Questionnaire Administration</intervention_name>
    <description>Complete G8 screening tool</description>
    <arm_group_label>Health Services Research (G8 screening tool, referral)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Referral</intervention_name>
    <description>Receive referral</description>
    <arm_group_label>Health Services Research (G8 screening tool, referral)</arm_group_label>
    <other_name>Referral, referral, Referred</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Questionnaire Administration</intervention_name>
    <description>Ancillary studies</description>
    <arm_group_label>Health Services Research (G8 screening tool, referral)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  NURSES: Assigned to two designated cancer clinics at Sidney Kimmel Cancer Center&#xD;
             (SKCC) Center City, the Renal Cell Carcinoma (RCC) and Lymphoma/myeloma clinics&#xD;
&#xD;
          -  PATIENTS: 65 years and older&#xD;
&#xD;
          -  PATIENTS: Diagnosis of cancer&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        â€¢ PATIENTS: Inability to answer or have caregiver answer questions on screening tool&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Thomas Jefefrson University</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19107</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kristine Swartz, MD</last_name>
      <phone>215-955-2353</phone>
      <email>Kristine.Swartz@jefferson.edu</email>
    </contact>
    <investigator>
      <last_name>Kristine Swartz, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>February 10, 2021</study_first_submitted>
  <study_first_submitted_qc>March 4, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">March 9, 2021</study_first_posted>
  <last_update_submitted>August 31, 2021</last_update_submitted>
  <last_update_submitted_qc>August 31, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 1, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

